doxifluridine |
5-Deoxy-5-fluorouridine" |
5-fluoro-5-deoxyuridine |
Furtulon |
3094-09-5 |
5-Dfur" |
Uridine, 5-deoxy-5-fluoro- |
Doxifluridina |
Doxifluridinum |
Ro 21-9738 |
Ro 219738 |
5dFUrd |
1-(beta-D-5-Desoxyribofuranoxyl)-5-fluoruracil |
UNII-V1JK16Y2JP |
CHEMBL1130 |
V1JK16Y2JP |
Capecitabine related compound b |
1-((2R,3R,4S,5R)-3,4-dihydroxy-5-methyltetrahydrofuran-2-yl)-5-fluoropyrimidine-2,4(1H,3H)-dione |
CHEBI:31521 |
NCGC00093926-03 |
Flutron |
Doxifluridine (5-Fluoro-5-deoxyuridine) |
DSSTox_CID_2967 |
5FDUR |
DSSTox_RID_76809 |
DSSTox_GSID_22967 |
5-Doxifluridine" |
5-dFUrd |
Furtulon (TN) |
1-(2R,3R,4S,5R)-3,4-dihydroxy-5-methyl-tetrahydrofuran-2-yl-5-fluoro-pyrimidine-2,4-dione |
SMR000326811 |
CAS-3094-09-5 |
Uridine-5-deoxy-5-fluoro- |
SR-01000075886 |
Doxifluridine INN:JAN |
5-DFUR |
Doxifluridinum INN-Latin |
Doxifluridina INN-Spanish |
MFCD00866530 |
EINECS 221-440-1 |
5-Deoxy-5-fluorouridine |
5-Fluoro-5`-deoxyuridine |
SCHEMBL8094 |
Doxifluridine (JP17/INN) |
Lopac0_000537 |
MLS001332579 |
MLS001332580 |
MLS002172440 |
MLS002207077 |
DTXSID2022967 |
HMS2090C22 |
HMS2231I05 |
HMS3261L15 |
ACN-S003358 |
AMC 0101 |
AMY13408 |
HY-B0021 |
ZINC1319177 |
Tox21_111231 |
Tox21_500537 |
BDBM50132295 |
s2045 |
CAPECITABINE IMPURITY B (USP) |
AKOS015852921 |
AKOS015896821 |
Tox21_111231_1 |
CCG-204627 |
CS-1270 |
DB12947 |
KS-5065 |
LP00537 |
NSC 758890 |
SDCCGSBI-0050520.P002 |
1-(2R,3R,4S,5R)-3,4-dihydroxy-5-methyloxolan-2-yl-5-fluoropyrimidine-2,4-dione |
NCGC00093926-01 |
NCGC00093926-02 |
NCGC00093926-05 |
NCGC00093926-11 |
NCGC00261222-01 |
Ro-21-9738 |
SRI-11552-08 |
SRI-11552_09 |
5-Deoxy-5-Fluorouridine (5-Dfur) |
RO-219738 |
EU-0100537 |
D01309 |
F 8791 |
15185-EP2272827A1 |
15185-EP2275420A1 |
15185-EP2295055A2 |
15185-EP2295416A2 |
15185-EP2295426A1 |
15185-EP2295427A1 |
15185-EP2298748A2 |
15185-EP2298764A1 |
15185-EP2298765A1 |
15185-EP2298768A1 |
15185-EP2298778A1 |
15185-EP2305642A2 |
15185-EP2311453A1 |
15185-EP2311808A1 |
15185-EP2311829A1 |
15185-EP2316832A1 |
15185-EP2316833A1 |
094F095 |
Q1253473 |
SR-01000075886-1 |
SR-01000075886-5 |
5-DFUR (5-Deoxy-5-fluorouridine, Doxifluridine) |
BRD-K58262659-001-09-7 |
Capecitabine impurity B, European Pharmacopoeia (EP) Reference Standard |
Capecitabine Related Compound B, United States Pharmacopeia (USP) Reference Standard |
1-((2R,3R,4S,5R)-3,4-dihydroxy-5-methyl-tetrahydrofuran-2-yl)-5-fluoropyrimidine-2,4(1H,3H)-dione |
1-((2R,5R)-3,4-Dihydroxy-5-methyl-tetrahydro-furan-2-yl)-5-fluoro-1H-pyrimidine-2,4-dione |
1-((4S,2R,3R,5R)-3,4-Dihydroxy-5-methyloxolan-2-yl)-5-fluoro-1,3-dihydropyrimidine-2,4-dione |
1-(5-Deoxy-beta-D-ribofuranosyl)-5-fluoropyrimidine-2,4(1H,3H)-dione (5-Deoxy-5-fluorouridine)" |